ALNYLAM PHARMACEUTICALS, INC. Quarterly Current Ratio in % from Q1 2011 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Alnylam Pharmaceuticals, Inc. quarterly Current Ratio history and growth rate from Q1 2011 to Q3 2024.
  • Alnylam Pharmaceuticals, Inc. Current Ratio for the quarter ending September 30, 2024 was 299 %, a 11.6% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 299 -39.2 -11.6% Sep 30, 2024
Q2 2024 310 -38.1 -10.9% Jun 30, 2024
Q1 2024 315 -47.3 -13.1% Mar 31, 2024
Q4 2023 326 -46 -12.3% Dec 31, 2023
Q3 2023 338 -48.7 -12.6% Sep 30, 2023
Q2 2023 348 -62.4 -15.2% Jun 30, 2023
Q1 2023 362 -75.7 -17.3% Mar 31, 2023
Q4 2022 372 -80.9 -17.8% Dec 31, 2022
Q3 2022 387 -80.4 -17.2% Sep 30, 2022
Q2 2022 410 -79.7 -16.3% Jun 30, 2022
Q1 2022 438 -66.2 -13.1% Mar 31, 2022
Q4 2021 453 -45.1 -9.05% Dec 31, 2021
Q3 2021 467 -48.2 -9.36% Sep 30, 2021
Q2 2021 490 -25 -4.86% Jun 30, 2021
Q1 2021 504 -25 -4.73% Mar 31, 2021
Q4 2020 498 -99 -16.6% Dec 31, 2020
Q3 2020 515 -134 -20.6% Sep 30, 2020
Q2 2020 515 -255 -33.1% Jun 30, 2020
Q1 2020 529 -435 -45.2% Mar 31, 2020
Q4 2019 597 -484 -44.7% Dec 31, 2019
Q3 2019 649 -623 -49% Sep 30, 2019
Q2 2019 770 -483 -38.6% Jun 30, 2019
Q1 2019 964 -187 -16.2% Mar 31, 2019
Q4 2018 1.08K +122 +12.7% Dec 31, 2018
Q3 2018 1.27K +535 +72.6% Sep 30, 2018
Q2 2018 1.25K +541 +76% Jun 30, 2018
Q1 2018 1.15K +387 +50.5% Mar 31, 2018
Q4 2017 960 +1.32 +0.14% Dec 31, 2017
Q3 2017 737 -613 -45.4% Sep 30, 2017
Q2 2017 712 -883 -55.3% Jun 30, 2017
Q1 2017 765 -911 -54.4% Mar 31, 2017
Q4 2016 958 -643 -40.1% Dec 31, 2016
Q3 2016 1.35K +46.4 +3.56% Sep 30, 2016
Q2 2016 1.59K +423 +36.1% Jun 30, 2016
Q1 2016 1.68K +579 +52.8% Mar 31, 2016
Q4 2015 1.6K +659 +70% Dec 31, 2015
Q3 2015 1.3K +403 +44.7% Sep 30, 2015
Q2 2015 1.17K +444 +61% Jun 30, 2015
Q1 2015 1.1K +551 +101% Mar 31, 2015
Q4 2014 942 +513 +120% Dec 31, 2014
Q3 2014 901 +523 +138% Sep 30, 2014
Q2 2014 728 +331 +83.6% Jun 30, 2014
Q1 2014 546 +145 +36.2% Mar 31, 2014
Q4 2013 429 +71.7 +20.1% Dec 31, 2013
Q3 2013 378 +55.6 +17.2% Sep 30, 2013
Q2 2013 396 +135 +51.5% Jun 30, 2013
Q1 2013 401 +178 +79.4% Mar 31, 2013
Q4 2012 357 +142 +65.9% Dec 31, 2012
Q3 2012 323 +92.9 +40.4% Sep 30, 2012
Q2 2012 261 +18.9 +7.77% Jun 30, 2012
Q1 2012 224 -30.4 -12% Mar 31, 2012
Q4 2011 215 Dec 31, 2011
Q3 2011 230 Sep 30, 2011
Q2 2011 243 Jun 30, 2011
Q1 2011 254 Mar 31, 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.